Drug reference

ceftobiprole

Fifth-generation cephalosporin · Antibiotic

Fifth-generation cephalosporinAntibiotic

CDSCO approved

EXCRETION

—

not curated

INTERACTIONS

—

none in our sources

PREGNANCY

—

not curated

Mechanism

A new antibiotic with excellent activity against both MRSA and methicillin-susceptible S. aureus (MSSA).

Indications

Complicated staphylococcal bacteremiasSkin and soft tissue infections (SSTIs)PneumoniaPenicillin-resistant, methicillin-sensitive S. aureus infections (alternative)

Related guidelines

Skin and soft tissue infections

IDSA · Infectious Diseases · 2010

Community-acquired pneumonia

ICMR · Pulmonology · 2022

Community-acquired pneumonia

IDSA · Pulmonology · 2019

Drug-resistant tuberculosis

RNTCP · Pulmonology · 2025

Childhood pneumonia and respiratory infection

MOHFW · Paediatrics · 2021

Ask House about ceftobiprole

Continue into a citation-backed clinical answer with the drug context already attached.

Open in workspace Ask House about this drug

Sources: Harrison 22e·Verified: 2026-05-10 · House clinical team